All Stories

  1. The need for holistic management of behavioral disturbances in dementia
  2. A comparison of the neuropsychological profiles of people living in squalor without hoarding to those living in squalor associated with hoarding
  3. Managing behavioural and psychological symptoms in dementia
  4. The Clinical and Service Outcomes of Unilateral and Bilateral ECT Electrode Placements in Australian Aged Psychiatry Services
  5. Uptake of a newly implemented advance care planning program in a dementia diagnostic service
  6. Efficacy and safety of once-monthly paliperidone palmitate long-acting injection in an elderly patient with schizophrenia: Table 1
  7. A preliminary investigation of domestic squalor in people with a history of alcohol misuse: neuropsychological profile and hoarding behavior – an opportunistic observational study
  8. A guide to clinical research supervision for psychiatrists: a mentoring approach
  9. Getting started in research: designing and preparing to conduct a research study
  10. Getting started in research: systematic reviews and meta-analyses
  11. Getting started in research: research questions, supervisors and literature reviews
  12. Domestic squalor: Who should take responsibility?
  13. Neuropsychological characteristics of people living in squalor
  14. Psychotropic drug use in aged care facilities: a reflection of a systemic problem?
  15. Perceptions of psychiatry of old age amongst psychiatry registrars in Australia and New Zealand
  16. The change in electrical energy delivered to aged patients over a course of moderate dose unilateral electroconvulsive therapy
  17. Predictors of adherence to atypical antipsychotics (risperidone or olanzapine) in older patients with schizophrenia: an open study of 3½ years duration
  18. Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial
  19. A comparison of the efficacy and safety of olanzapine and risperidone in the treatment of elderly patients with schizophrenia: an open study of six months duration
  20. Imaginem oblivionis: the prospects of neuroimaging for early detection of Alzheimer's disease
  21. Antwone Fisher: how dangerous is 'Dr Wonderful'?
  22. Metal-Protein Attenuation With Iodochlorhydroxyquin (Clioquinol) Targeting Aβ Amyloid Deposition and Toxicity in Alzheimer Disease
  23. Why Participate in an Alzheimers Disease Clinical Trial? Is It of Benefit to Carers and Patients?
  24. The impact upon extra-pyramidal side effects, clinical symptoms and quality of life of a switch from conventional to atypical antipsychotics (risperidone or olanzapine) in elderly patients with schizophrenia
  25. Carer Impressions of Participation in Alzheimers Disease Clinical Trials: What Are Their Hopes? And Is It Worth It?